Disclosure Index: S
Disclosure Index: S
Novartis:
Research grants
Pfizer: Research grants
Roche: Research grants
Sage Therapeutics: Scientific Advisory Board
Pfizer: Research grants
Roche: Research grants
Sage Therapeutics: Scientific Advisory Board
HealthTracker Ltd:
Director and shareholder. The HealthTracker platform is used in the study.
Pearson Assessments:
Receipt of royalties
Neuren, Coronado, Roche, Supernus, MedAdvante, Bracket:
Consulting fees
Lineagen:
Employment (full or part-time)
InVitae:
Consulting fees
and
Stock
InVitae:
Consulting fees
and
Stock
Janssen:
Consulting fees
and
Research grants
Roche: Research grants
Roche: Research grants
Neuren Phamaceutical:
Consulting fees
Akili Interactive: research contract with my employer DCRI
Curemark Pharmaceutical: contract to be treatment site on industry study
F Hoffman-LaRoche: contract to be treatment site on 2 industry studies
Marcus Foundation: Research grants and Some of my effort is supported by research grant to Drs. Dawson & Kurtzberg from Marcus, I do not personally have a grant from them.
Akili Interactive: research contract with my employer DCRI
Curemark Pharmaceutical: contract to be treatment site on industry study
F Hoffman-LaRoche: contract to be treatment site on 2 industry studies
Marcus Foundation: Research grants and Some of my effort is supported by research grant to Drs. Dawson & Kurtzberg from Marcus, I do not personally have a grant from them.
Janssen Reseach & Development, LLC:
Employment (full or part-time)
Stemina Biomarker Disocvery:
Employment (full or part-time)
SARRC:
Employment (full or part-time)
Harimata:
Ownership or partnership
Everest:
Non-remunerative
Maccabi Healthcare Services:
Employment (full or part-time)
Center for Promotion of Child Development through Primary Care:
Employment (full or part-time)
Vanderbilt University:
Receipt of royalties
Total Child Health:
Ownership or partnership
Stemina Biomarker Discovery:
Employment (full or part-time)
Takeda:
Consulting fees